missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Biochemical Reagents
  4. Peptides
  5. 18120853

Novus Biologicals™ STING/TMEM173 Antibody Blocking Peptide

Highly purified. Generating reliable and reproducible results.

Brand:  Novus Biologicals™ NBP2-24683PEP

Product Code. 18120853

  • 1720.00 SEK / 0.05mg

Please to purchase this item. Need a web account? Register with us today!

Explore more special offers
This item is not returnable. View return policy

Description

Description

The STING/TMEM173 Blocking Peptide has been validated for the following applications: Antibody Competition.
Specifications

Specifications

340061
STING/TMEM173
diH2O
anti-STING, endoplasmic reticulum IFN stimulator, Endoplasmic reticulum interferon stimulator, ERIS, FLJ38577, hMITA, hSTING, human STING, Mediator of IRF3 activation, MITA, mitochondrial mediator of IRF3 activation, mouse STING, MPYS, NET23, N-terminal methionine-proline-tyrosine-serine plasma membrane tetraspanner, SAVI, Stimulator of interferon genes protein, stimulator of interferon protein, sting, STING-beta, TMEM173, transmembrane protein 173
M.W. (theoretical): 42 kDa
Cancer, Immunology, Innate Immunity
Human
Store at -80 C. Avoid freeze-thaw cycles.
This Peptide is Useful as a Blocking Peptide for NBP2-24683. For Further Blocking Peptide Related Protocol, Click Here .
TMEM173
0.05 mg
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Special Offers

Special Offers

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.